Anzeige
Mehr »
Login
Dienstag, 15.06.2021 Börsentäglich über 12.000 News von 663 internationalen Medien
InnoCan Pharma meldet elftes Patent an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12GAQ ISIN: CA64129Y1079 Ticker-Symbol: 1N9 
Tradegate
14.06.21
17:31 Uhr
0,110 Euro
+0,004
+3,30 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEUTRISCI INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
NEUTRISCI INTERNATIONAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1060,11608:57
0,1100,12008:57

Aktuelle News zur NEUTRISCI Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiNeutriSci International Inc: NeutriSci produces Tabletz sticks for Biople12
MiNeutriSci International Inc: Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan278VANCOUVER, BC / ACCESSWIRE / June 9, 2021 / NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products, licensing...
► Artikel lesen
NEUTRISCI Aktie jetzt für 0€ handeln
27.05.NeutriSci International Inc: NeutriSci Completes R&D and Expands Product Selection to Include Beverages444VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU, OTCQB:NRXCF, FRANKFURT: 1N9), an innovative technology company developing products...
► Artikel lesen
25.05.NeutriSci International Inc: NeutriSci to provide Pacwest with IP access13
25.05.NeutriSci International Inc: NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development338VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing...
► Artikel lesen
10.05.NeutriSci International Inc: NeutriSci completes phase 1 R&D for CBN product18
10.05.NeutriSci International Inc: Neutrisci Announces Successful Completion of Phase 1 R&D Development of a Cannabinol Product489VANCOUVER, BC / ACCESSWIRE / May 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing products...
► Artikel lesen
03.05.NeutriSci International Inc: NeutriSci receives another order for Tabletz12
03.05.NeutriSci erhält weitere Bestellung für den japanischen Markt345Vancouver (British Columbia), 3. Mai 2021 - NeutriSci International Inc. (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) ("NeutriSci" oder das "Unternehmen"), ein innovatives Technologieunternehmen...
► Artikel lesen
03.05.NeutriSci International Inc: Neutrisci Receives Additional Order for Japanese Market376VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products for the nutraceutical...
► Artikel lesen
18.03.NeutriSci International Inc: NeutriSci completes Vegas production line, research lab24
18.03.NeutriSci nimmt neue hochmoderne Produktions- und Forschungsanlage in Las Vegas, Nevada, USA, in Betrieb486Vancouver, British Columbia - 18. März 2021 - NeutriSci International Inc. ("NeutriSci" oder das "Unternehmen") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), ein innovatives Technologieunternehmen...
► Artikel lesen
18.03.NeutriSci International Inc: Neutrisci Announces New State-Of-The-Art Production and Research Facility in Las Vegas, Nevada, USA349VANCOUVER, BC / ACCESSWIRE / March 18, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products...
► Artikel lesen
08.03.NeutriSci International Inc: NeutriSci receives Tabletz HC code approval in Japan22
08.03.NeutriSci: Tabletz LLC. erhält HS-Zollklassifizierung in Japan506Vancouver, British Columbia - 8. März 2021 - NeutriSci International Inc. ("NeutriSci" oder das "Unternehmen") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), ein innovatives Technologieunternehmen...
► Artikel lesen
08.03.NeutriSci International Inc: NeutriSci: Harmonized Code Approval Received by TABLETZ LLC., in Japan552VANCOUVER, BC / ACCESSWIRE / March 8, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products for the...
► Artikel lesen
09.02.NeutriSci International Inc: NeutriSci Int'l 2,467,000-share private placement78
30.01.NeutriSci International Inc: NeutriSci closes $370,050 private placement63
30.01.NeutriSci International Inc: NeutriSci Closes Financing904VANCOUVER, BC / ACCESSWIRE / January 29, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products...
► Artikel lesen
18.01.NeutriSci International Inc: NeutriSci receives Tabletz order in Japan98
Seite:  Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,4,38